Call Anytime

669 2568 2596

Lorem ipsum dolor sit amet, consectet eiusmod tempor incididunt ut labore e rem ipsum dolor sit amet. sum dolor sit amet, consectet eiusmod.

Visiting Hours

Gallery Posts

Hepatic Venous portal gradient measurement

Hepatic Venous portal gradient measurement

Hepatic venous portal gradient (HVPG) measurement is a procedure used to assess the pressure within the portal vein and the hepatic vein. It is an important diagnostic tool in evaluating portal hypertension, a condition characterized by increased pressure in the portal vein system, often associated with liver disease. 

 

Indications for HVPG Measurement

  1. Portal Hypertension: Suspected or known portal hypertension, which can be caused by liver cirrhosis, hepatitis, portal vein thrombosis, or other liver diseases (Click here to read more on Portal Hypertension) (Click here to read more on Liver Cirrhosis) 
  2. Risk Assessment: Evaluating the risk of variceal bleeding in patients with portal hypertension.
  3. Monitoring: Monitoring the response to medical treatment or interventions aimed at reducing portal hypertension.

 

Procedure Overview

  1. Pre-procedure Preparation:
    • Patient assessment, including medical history, physical examination, liver function tests, imaging studies (such as ultrasound, CT scan), and assessment of coagulation profile.
    • Explanation of the procedure, risks, benefits, and obtaining informed consent.
  2. Patient Positioning:
    • The patient is typically positioned supine on the procedure table.
  3. Anesthesia:
    • Local anesthesia is administered at the puncture site, usually the right internal jugular vein.
  4. Catheter Insertion:
    • A catheter is inserted into the right internal jugular vein using ultrasound guidance to visualize the vein and guide the placement of the catheter.
    • The catheter is advanced through the inferior vena cava into the hepatic vein, which drains blood from the liver.
  5. Pressure Measurement:
    • Once the catheter is in the hepatic vein, pressure measurements are obtained using a manometer or pressure transducer system.
    • The first pressure measured is the hepatic venous pressure (HVP), which reflects the pressure in the hepatic vein.
    • Subsequently, a balloon catheter is inflated in a smaller branch of the hepatic vein to temporarily block blood flow and measure the wedged hepatic venous pressure (WHVP), which reflects the pressure within the liver sinusoids.
    • The portal venous pressure (PVP) is then measured by subtracting the WHVP from the HVP, giving the hepatic venous portal gradient (HVPG).
  6. Calculating HVPG:
    • HVPG = PVP (Portal Venous Pressure) – WHVP (Wedged Hepatic Venous Pressure).
  7. Recording and Interpretation:
    • The HVPG measurement is recorded, and the results are interpreted to assess the severity of portal hypertension and the risk of complications such as variceal bleeding.
    • HVPG values are classified as follows:
      • HVPG < 5 mmHg: Normal portal pressure.
      • HVPG 5-9 mmHg: Mild portal hypertension.
      • HVPG 10-19 mmHg: Moderate portal hypertension.
      • HVPG ≥ 20 mmHg: Severe portal hypertension.

 

Post-procedure Care

  1. Monitoring:
    • Continuous monitoring of the patient’s vital signs, oxygen saturation, and catheter insertion site.
    • Observation for any signs of bleeding, hematoma formation, or complications related to the procedure.
  2. Patient Discharge:
    • Once stable and without complications, the patient may be discharged with instructions for follow-up care.
  3. Follow-up:
    • Follow-up appointments are scheduled to review the HVPG results, discuss management strategies based on the findings, and monitor the patient’s liver function and portal hypertension over time.

 

Benefits and Clinical Utility of HVPG Measurement

  • Assessment of Portal Hypertension: Provides quantitative information on the degree of portal hypertension, which is crucial for risk stratification and treatment decisions.
  • Risk Prediction: Helps predict the risk of variceal bleeding and guide the use of preventive measures such as beta-blockers or variceal band ligation.
  • Monitoring Response to Treatment: Allows monitoring of the response to medical therapy (e.g., portal pressure-reducing medications) or interventional procedures aimed at reducing portal hypertension.
  • Prognostic Information: HVPG measurement is also prognostic, as higher HVPG values are associated with an increased risk of complications and mortality in patients with liver cirrhosis and portal hypertension.

 

Risks and Considerations

  • Bleeding and Hematoma: Risk of bleeding or hematoma formation at the catheter insertion site.
  • Infection: Risk of catheter-related infection, although rare with proper aseptic techniques.
  • Arrhythmias: Potential for transient arrhythmias during catheter insertion or manipulation.

 

Overall, HVPG measurement is a valuable tool in the assessment and management of portal hypertension, providing essential information for risk stratification, treatment decisions, and prognostic assessment in patients with liver disease and portal hypertension. Close monitoring, adherence to aseptic techniques, and post-procedure care are essential to minimize risks and optimize patient outcomes.